Biolab, a Brazilian pharmaceutical company, has been selected by the UN-backed Medicines Patent Pool to manufacture and sell baloxavir marboxil (Xofluza), Roche’s single-dose oral influenza treatment, in Brazil under a …
Biolab, a Brazilian pharmaceutical company, has been selected by the UN-backed Medicines Patent Pool to manufacture and sell baloxavir marboxil (Xofluza), Roche’s single-dose oral influenza treatment, in Brazil under a …
Argentina’s ANMAT preventively halted all production and sales by Trifarma S.R.L. and Ugal Farmacéutica S.A. and prohibited all their products nationwide, citing technical director and quality control deficiencies.
Ecuador’s government is in talks with Colombia, India, Argentina, and Costa Rica to procure medicines for public hospitals, as shortages and a trade dispute with Colombia strain the health system.
An Argentine federal judge has formally indicted the former heads of ANMAT and INAME as necessary participants in the adulteration of fentanyl linked to 90 deaths, ordering embargoes of 500 …
Ecuador’s Sercop signed 114 medication supply agreements in May–June 2026, but 71 carry no purchase orders as of mid-August — leaving contracted suppliers unpaid and public hospital shelves empty.
Clinics across four Patagonian provinces suspended all PAMI patient care for 24 hours, citing a 143% tariff adjustment against 341% cumulative inflation — a gap that may signal broader provider …
Brazilian startup PoliHealth is integrating genetic, laboratory, and lifestyle data into a single AI platform for clinicians, targeting R$8 million in revenue and 30,000 health professional users within three years.
PASSUS IPS, a Colombian healthcare provider, has warned it may suspend services due to unpaid debts from EPS insurers, exposing a structural financing gap in Colombia’s health system.
You must be logged in to post a comment.